Peer Review reports
From: Reframing cancer: challenging the discourse on cancer and cancer drugs—a Norwegian perspective
| Original Submission | ||
|---|---|---|
| 23 Feb 2021 | Submitted | Original manuscript |
| 11 Mar 2021 | Author responded | Author comments - Mille Sofie Stenmarck |
| Resubmission - Version 2 | ||
| 11 Mar 2021 | Submitted | Manuscript version 2 |
| 15 Jun 2021 | Reviewed | Reviewer Report |
| 28 Jun 2021 | Reviewed | Reviewer Report |
| 17 Aug 2021 | Author responded | Author comments - Mille Sofie Stenmarck |
| Resubmission - Version 3 | ||
| 17 Aug 2021 | Submitted | Manuscript version 3 |
| 5 Sep 2021 | Author responded | Author comments - Mille Sofie Stenmarck |
| Resubmission - Version 4 | ||
| 5 Sep 2021 | Submitted | Manuscript version 4 |
| Publishing | ||
| 9 Sep 2021 | Editorially accepted | |
| 21 Sep 2021 | Article published | 10.1186/s12910-021-00693-5 |
You can find further information about peer review here.